Karnataka receives additional vials of Amphotericin B, Covishield and Remdesivir

Karnataka received an additional 1,030 vials of Amphotericin-B drug used in the treatment of Mucormycosis (Black Fungus Infection). Earlier, 1270 vials of the drug were allocated on 21st May.

Union Minister for Chemicals and Fertilizers DV Sadananda Gowda said that an additional 19,420 vials of Amphotericin-B drug have been allocated to all states/UT and Central institutions yesterday.

Karnataka received around 3 Lakh doses of Covishield under the Central quota yesterday. Announcing the same on Twitter, Minister of Health and Family Welfare Sudhakar K said that Karnataka has received 1.05 crore Covishield doses from the center.

Karnataka Government has purchased around 13.54 Lakh doses of Covishield so far. Whereas, it has received 13.10 Lakhs of Covaxin doses.

A total of 4.25 Lakhs vials of Remdesivir, the highest among all states have been allocated to Karnataka for the period between 23rd to 30th May.

So far, approximately 10 Lakh vials of Remdesivir have already been made available to the state till May 23. Also, a total of 14.25Lakh vials of the drug have been allocated to the state till 30th May.

The state is experiencing a shortage in the supply of Covaxin. So the government has decided to utilize the available stock of Covaxin to vaccinate beneficiaries who are due for 2nd dose.

“All the private health care institutions should utilize the available stock of Covaxin at their respective health facility as the second dose for the age group 45 plus who are waiting for the second dose of Covaxin as per the Covid vaccination schedule of Government of India,” said GoK in a press release.

Share this article!

Leave a Reply

Your email address will not be published.

error: Content is protected !!